Guidelines and policies
Association of triglyceride lowering LPL variants and LDL-C lowering LDLR variants with risk of coronary heart disease Ference, M., Kastelein, J., Ray, K et al (2019)
Source: JAMA. 321. 4. 364-373
Low density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic and clinical studies. A consensus statement from the European Atherosclerosis Society Panel
Source: European Heart Journal
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study
Source: The Lancet
Joint British Societies for the Prevention of Cardiovascular Disease (2014) Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
National Institute for Health and Care Excellence (2014) Cardiovascular disease: risk assessment and reduction, including lipid modification
Scottish Intercollegiate Guidelines Network (SIGN) Risk estimation and the prevention of cardiovascular disease.
Public Health England (2014) Adult obesity and type 2 diabetes.